Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS | 13 | 22 | -0,47 % | ||
| BIONTECH | 6 | 13 | +0,11 % | ||
| MEDPACE | 5 | - | -0,39 % | ||
| ALTIMMUNE | 3 | - | -0,81 % | ||
| CORVUS PHARMACEUTICALS | 3 | - | -2,85 % | ||
| BIOMARIN PHARMACEUTICAL | 2 | 12 | +0,61 % | ||
| TECTONIC THERAPEUTIC | 2 | 1 | 0,00 % | ||
| BLACK DIAMOND THERAPEUTICS | 2 | - | 0,00 % | ||
| AMGEN | 1 | 27 | +0,57 % | ||
| KINIKSA PHARMACEUTICALS | 1 | 11 | -0,12 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06:30 | Regeneron Pharma: FDA Grants Approval For Otarmeni, Gene Therapy For Genetic Hearing Loss | 163 | AFX News | LONDON (dpa-AFX) - Regeneron Pharmaceuticals (REGN) announced the FDA has granted accelerated approval for Otarmeni, the first gene therapy and second new molecular entity approved under the... ► Artikel lesen | |
| 01:46 | Regeneron Gets Landmark FDA Approval for First Gene Therapy for Hearing Loss | 5 | MedCity News | ||
| 00:48 | Medpace sees $1.94B backlog conversion over next 12 months as cancellations rise | 1 | Seeking Alpha | ||
| Do | Novavax (NVAX) Dips More Than Broader Market: What You Should Know | 4 | Zacks | ||
| Do | FDA approves Regeneron's hearing loss gene therapy | 3 | BioPharma Dive | ||
| Do | Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval | 2 | FiercePharma | ||
| Do | Regeneron: Kostenlose Gentherapie und globale Preisanpassung für US-Markt | 2 | Investing.com Deutsch | ||
| Do | Regeneron to offer gene therapy free, align U.S. drug prices globally | 4 | Investing.com | ||
| Do | Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors | 1 | GlobeNewswire (USA) | ||
| Do | Kiniksa Pharmaceuticals International, Plc: Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026 | 1 | GlobeNewswire (USA) | ||
| Do | Dyne Therapeutics, Inc.: Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 1 | GlobeNewswire (USA) | ||
| Do | Trevi Therapeutics, Inc.: Trevi Therapeutics to Participate in Upcoming May Events | 1 | GlobeNewswire (USA) | ||
| Do | Regeneron Pharmaceuticals, Inc.: Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S. | 2 | GlobeNewswire (USA) | ||
| Do | Tectonic Therapeutic, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Do | Corvus Pharmaceuticals, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Do | BIOMARIN PHARMACEUTICAL INC - 8-K, Current Report | - | SEC Filings | ||
| Do | Regeneron to unveil latest 'most favored nation' drug pricing deal with White House | 2 | FiercePharma | ||
| Do | Medpace Flags Rising Cancellations, Near-Term Growth Uncertain | 3 | Benzinga.com | ||
| Do | With Dupixent driving growth, Sanofi touts 'vigorous defense' to extend US exclusivity | 4 | FiercePharma | ||
| Do | Regeneron wins FDA approval for hearing loss therapy | 4 | Seeking Alpha |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.